Crohn's disease: Difference between revisions

(Prepared the page for translation)
(Marked this version for translation)
 
Line 2: Line 2:
<translate>
<translate>


==Background==
==Background== <!--T:1-->


<!--T:2-->
*Can involve any part of the GI tract from the mouth to the anus
*Can involve any part of the GI tract from the mouth to the anus
*Bimodal distribution: 15-22yr, 55-60yr
*Bimodal distribution: 15-22yr, 55-60yr
Line 16: Line 17:




==Clinical Features==
==Clinical Features== <!--T:3-->


<!--T:4-->
[[File:Aphthous stomatitis.jpg|thumb|An aphthous mouth ulcer ([[Special:MyLanguage/aphthous stomatitis|aphthous stomatitis]]) on seen with Crohn's disease.]]
[[File:Aphthous stomatitis.jpg|thumb|An aphthous mouth ulcer ([[Special:MyLanguage/aphthous stomatitis|aphthous stomatitis]]) on seen with Crohn's disease.]]
[[File:A single EN.jpg|thumb|A single lesion of erythema nodosum.]]
[[File:A single EN.jpg|thumb|A single lesion of erythema nodosum.]]


===GI Symptoms===
===GI Symptoms=== <!--T:5-->


<!--T:6-->
*[[Special:MyLanguage/Abdominal pain|Abdominal pain]]
*[[Special:MyLanguage/Abdominal pain|Abdominal pain]]
*[[Special:MyLanguage/Diarrhea|Diarrhea]]
*[[Special:MyLanguage/Diarrhea|Diarrhea]]
Line 29: Line 32:




===Extraintestinal Symptoms (50%)===
===Extraintestinal Symptoms (50%)=== <!--T:7-->


<!--T:8-->
*[[Special:MyLanguage/Arthritis|Arthritis]]
*[[Special:MyLanguage/Arthritis|Arthritis]]
**Peripheral [[Special:MyLanguage/arthritis|arthritis]]
**Peripheral [[Special:MyLanguage/arthritis|arthritis]]
Line 60: Line 64:




==Differential Diagnosis==
==Differential Diagnosis== <!--T:9-->


</translate>
</translate>
Line 66: Line 70:
<translate>
<translate>


===Other===
===Other=== <!--T:10-->


<!--T:11-->
*[[Special:MyLanguage/Appendicitis|Appendicitis]]
*[[Special:MyLanguage/Appendicitis|Appendicitis]]




==Evaluation==
==Evaluation== <!--T:12-->




===Work-Up===
===Work-Up=== <!--T:13-->


<!--T:14-->
*Rule out alternate etiologies for symptoms
*Rule out alternate etiologies for symptoms
*Evaluate for complications (e.g. fistulae, abscess, obstruction)
*Evaluate for complications (e.g. fistulae, abscess, obstruction)
Line 88: Line 94:
***[[Special:MyLanguage/Clostridium difficile|C.diff]] toxin
***[[Special:MyLanguage/Clostridium difficile|C.diff]] toxin


<!--T:15-->
*Consider imaging:
*Consider imaging:
**CT A/P if concern for [[Special:MyLanguage/small bowel obstruction|small bowel obstruction]], perforation, or toxic megacolon
**CT A/P if concern for [[Special:MyLanguage/small bowel obstruction|small bowel obstruction]], perforation, or toxic megacolon
Line 94: Line 101:




===Diagnosis===
===Diagnosis=== <!--T:16-->




==Management==
==Management== <!--T:17-->


<!--T:18-->
[[File:CT scan gastric CD.jpg|thumb|CT scan showing Crohn's disease in the fundus of the stomach.]]
[[File:CT scan gastric CD.jpg|thumb|CT scan showing Crohn's disease in the fundus of the stomach.]]


===Acute Flare Management===
===Acute Flare Management=== <!--T:19-->


<!--T:20-->
*[[Special:MyLanguage/IVF|IVF]]
*[[Special:MyLanguage/IVF|IVF]]
*Bowel rest
*Bowel rest
Line 113: Line 122:




===Chronic Treatment===
===Chronic Treatment=== <!--T:21-->


<!--T:22-->
''Alterations should be discussed with GI''
''Alterations should be discussed with GI''
*Aminosalicylates (5-ASA) - Mild-to-moderate Crohn's disease. Give with probiotics.
*Aminosalicylates (5-ASA) - Mild-to-moderate Crohn's disease. Give with probiotics.
Line 145: Line 155:




==Disposition==
==Disposition== <!--T:23-->




===Inpatient Admission===
===Inpatient Admission=== <!--T:24-->


<!--T:25-->
*Significant metabolic derangements (i.e. [[Special:MyLanguage/electrolyte imbalance|electrolyte imbalance]] or severe [[Special:MyLanguage/dehydration|dehydration]])
*Significant metabolic derangements (i.e. [[Special:MyLanguage/electrolyte imbalance|electrolyte imbalance]] or severe [[Special:MyLanguage/dehydration|dehydration]])
*Fulminate [[Special:MyLanguage/colitis|colitis]]
*Fulminate [[Special:MyLanguage/colitis|colitis]]
Line 157: Line 168:




===Surgical Intervention===
===Surgical Intervention=== <!--T:26-->


<!--T:27-->
''Consult EARLY if any of the following suspicions''
''Consult EARLY if any of the following suspicions''
*Perforation
*Perforation
Line 169: Line 181:




==Complications==
==Complications== <!--T:28-->


<!--T:29-->
*[[Special:MyLanguage/Bowel obstruction|Bowel obstruction]]
*[[Special:MyLanguage/Bowel obstruction|Bowel obstruction]]
**Due to stricture or bowel wall edema
**Due to stricture or bowel wall edema
Line 189: Line 202:




===Therapy complications===
===Therapy complications=== <!--T:30-->


<!--T:31-->
*[[Special:MyLanguage/Leukopenia|Leukopenia]]/[[Special:MyLanguage/thrombocytopenia|thrombocytopenia]]
*[[Special:MyLanguage/Leukopenia|Leukopenia]]/[[Special:MyLanguage/thrombocytopenia|thrombocytopenia]]
*[[Special:MyLanguage/Fever|Fever]]/infection
*[[Special:MyLanguage/Fever|Fever]]/infection
Line 197: Line 211:




==See Also==
==See Also== <!--T:32-->


<!--T:33-->
*[[Special:MyLanguage/Ulcerative Colitis|Ulcerative Colitis]]
*[[Special:MyLanguage/Ulcerative Colitis|Ulcerative Colitis]]
*[[Special:MyLanguage/Colitis|Colitis]]
*[[Special:MyLanguage/Colitis|Colitis]]




==References==
==References== <!--T:34-->


<!--T:35-->
<references/>
<references/>
[[Category:GI]]
[[Category:GI]]
1. Thomas N, Wu AW. Large intestine. In: Walls RM, Hockberger RS, Gausche-Hill M, et al., eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 10th ed. Elsevier; 2023.
1. Thomas N, Wu AW. Large intestine. In: Walls RM, Hockberger RS, Gausche-Hill M, et al., eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 10th ed. Elsevier; 2023.
</translate>
</translate>

Latest revision as of 12:54, 14 January 2026

Other languages:
  • English

Background

  • Can involve any part of the GI tract from the mouth to the anus
  • Bimodal distribution: 15-22yr, 55-60yr
  • Pathology
    • All layers of the bowel are involved
      • Reason why fistulas and abscesses are common complications
    • "Skip lesions" are common

Crohn's disease vs. ulcerative colitis

Finding Crohn's disease Ulcerative colitis
Depth of inflammation May be transmural, deep into tissues Shallow, mucosal
Distribution of disease Patchy areas of inflammation (skip lesions) Continuous area of inflammation
Terminal ileum involvement Commonly Seldom
Colon involvement Usually Always
Rectum involvement Seldom Usually (95%)
Involvement around anus Common Seldom
Stenosis Common Seldom


Clinical Features

An aphthous mouth ulcer (aphthous stomatitis) on seen with Crohn's disease.
A single lesion of erythema nodosum.

GI Symptoms


Extraintestinal Symptoms (50%)


Differential Diagnosis

Colitis

Other


Evaluation

Work-Up

  • Rule out alternate etiologies for symptoms
  • Evaluate for complications (e.g. fistulae, abscess, obstruction)
  • Labs
    • CBC
    • Chemistry
    • LFTs/lipase
    • May additionally consider:
      • ESR/CRP
      • Type and screen (if concern for significant bleeding)
      • Fecal calprotectin (sensitive indicator of intestinal inflammation, unreliable in select Crohn's patients)[1]
      • C.diff toxin
  • Consider imaging:
    • CT A/P if concern for small bowel obstruction, perforation, or toxic megacolon
      • Most useful diagnostic test in patients with acute symptoms who have known or suspected Crohn
      • Findings: bowel wall thickening, mesenteric edema, local abscess, fistulas


Diagnosis

Management

CT scan showing Crohn's disease in the fundus of the stomach.

Acute Flare Management


Chronic Treatment

Alterations should be discussed with GI

  • Aminosalicylates (5-ASA) - Mild-to-moderate Crohn's disease. Give with probiotics.
  • Anti-diarrheal - Use caution in patients with active inflammation as can precipitate toxic megacolon
  • Glucocorticoids - Symptomatic relief (course not altered)
    • Prednisone - 40-60mg/day with taper once remission induced
    • Methylprednisolone 20mg IV q6hr
    • Hydrocortisone 100mg q8hr
      • Do not start if any suspicion of infection (ie C. diff colitis)
      • Double edge sword: Reduction of bone density in addition to underlying disease process(decreased Ca absorption)
  • Antibiotics - Induce remission
  • Immunomodulators - Steroid-sparing agents used in fistulas and patients with surgical contraindication. Slower onset.
    • 6-Mercaptopurine 1-1.5mg/kg/day → Start at 50mg daily
    • Azathioprine 2-2.5mg/kg/day → Start at 50mg daily
    • Methotrexate IM
  • Anti-TNF - Medically resistant moderate-to-severe Crohn's disease
    • Infliximab (Remicade) 5mg/kg IV
    • Adalimumab (Humira), Natalizumab or certolizumab pegol can also be used


Disposition

Inpatient Admission


Surgical Intervention

Consult EARLY if any of the following suspicions


Complications

  • Bowel obstruction
    • Due to stricture or bowel wall edema
  • Abscess
    • Can be intraperitoneal, retroperitoneal, interloop, or intramesenteric
      • More severe abdominal pain than usual
      • Fever
      • Hip or back pain and difficulty walking (retroperitoneal abscess)
  • Fistula
    • Occurs due to extension of intestinal fissure into adjacent structures
    • Suspect if changes in patient's symptoms (e.g. BM frequency, amt of pain, wt loss)
  • Perianal disease
  • Hemorrhage
    • Erosion into a bowel wall vesel
  • Toxic megacolon
    • Can be associated with massive GI bleeding


Therapy complications


See Also


References

  1. van Rheenen PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ. 2010;15(341):c3369.

1. Thomas N, Wu AW. Large intestine. In: Walls RM, Hockberger RS, Gausche-Hill M, et al., eds. Rosen’s Emergency Medicine: Concepts and Clinical Practice. 10th ed. Elsevier; 2023.